tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
RIGL is currently covered by 2 analysts with an average price target of $64.4. This is a potential upside of $13.62 (51.24%) from yesterday's end of day stock price of $42.58.
Rigel Pharmaceuticals's activity chart (see below) currently has 32 price targets and 52 ratings on display. The stock rating distribution of RIGL is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 55.48% with an average time for these price targets to be met of 427.76 days.
Highest price target for RIGL is $85, Lowest price target is $42, average price target is $64.4.
Most recent stock forecast was given by JOSEPH PANTGINIS from HC WAINWRIGHT on 13-Aug-2026. First documented stock forecast 13-Jul-2016.
Currently out of the existing stock ratings of RIGL, 7 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 06-Mar-2018
$85
$42.42 (99.62%)
$57
Buy Since 09-Mar-2023
$69
$30.31 (78.34%)
$67
Buy Since 05-Nov-2025
$42
$16.19 (62.73%)
$23
Hold Since 10-Dec-2024
$32
$-6.69 (-17.29%)
$23
Hold Since 07-Aug-2024
$24
$-14.69 (-37.97%)
$20
What is RIGL (Rigel Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on RIGL (Rigel Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on RIGL (Rigel Pharmaceuticals)?
Which analyst is the currently most bullish on RIGL (Rigel Pharmaceuticals)?
Which analyst is the currently most reserved on RIGL (Rigel Pharmaceuticals)?
